Insys

The maker of a highly addictive fentanyl-based drug wants to sell its assets to pay some $250 million in debts. The move could let the company out of part of the settlement deal reached last week.

Federal prosecutors say the pharmaceutical company paid off doctors and manipulated insurance companies to increase the number of patients taking its opioid Subsys.